Literature DB >> 23882158

Structured reporting of T cell assay results.

Sylvia Janetzki1, Axel Hoos, Cornelis J M Melief, Kunle Odunsi, Pedro Romero, Cedrik M Britten.   

Abstract

Keywords:  MIATA; T cell assay

Mesh：

Year:  2013        PMID： 23882158      PMCID： PMC3718734     

Source DB:  PubMed          Journal:  Cancer Immun        ISSN： 1424-9634


× No keyword cloud information.
  15 in total

Review 1.  Harmonization of immune biomarker assays for clinical studies.

Authors:  Sjoerd H van der Burg; Michael Kalos; Cécile Gouttefangeas; Sylvia Janetzki; Christian Ottensmeier; Marij J P Welters; Pedro Romero; Cedrik M Britten; Axel Hoos
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

2.  T cell assays and MIATA: the essential minimum for maximum impact.

Authors:  C M Britten; S Janetzki; L H Butterfield; G Ferrari; C Gouttefangeas; C Huber; M Kalos; H I Levitsky; H T Maecker; C J M Melief; J O'Donnell-Tormey; K Odunsi; L J Old; T H M Ottenhoff; C Ottensmeier; G Pawelec; M Roederer; B O Roep; P Romero; S H van der Burg; S Walter; A Hoos; M M Davis
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

3.  "MIATA"-minimal information about T cell assays.

Authors:  Sylvia Janetzki; Cedrik M Britten; Michael Kalos; Hyam I Levitsky; Holden T Maecker; Cornelius J M Melief; Lloyd J Old; Pedro Romero; Axel Hoos; Mark M Davis
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

4.  Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project.

Authors:  Chris F Taylor; Dawn Field; Susanna-Assunta Sansone; Jan Aerts; Rolf Apweiler; Michael Ashburner; Catherine A Ball; Pierre-Alain Binz; Molly Bogue; Tim Booth; Alvis Brazma; Ryan R Brinkman; Adam Michael Clark; Eric W Deutsch; Oliver Fiehn; Jennifer Fostel; Peter Ghazal; Frank Gibson; Tanya Gray; Graeme Grimes; John M Hancock; Nigel W Hardy; Henning Hermjakob; Randall K Julian; Matthew Kane; Carsten Kettner; Christopher Kinsinger; Eugene Kolker; Martin Kuiper; Nicolas Le Novère; Jim Leebens-Mack; Suzanna E Lewis; Phillip Lord; Ann-Marie Mallon; Nishanth Marthandan; Hiroshi Masuya; Ruth McNally; Alexander Mehrle; Norman Morrison; Sandra Orchard; John Quackenbush; James M Reecy; Donald G Robertson; Philippe Rocca-Serra; Henry Rodriguez; Heiko Rosenfelder; Javier Santoyo-Lopez; Richard H Scheuermann; Daniel Schober; Barry Smith; Jason Snape; Christian J Stoeckert; Keith Tipton; Peter Sterk; Andreas Untergasser; Jo Vandesompele; Stefan Wiemann
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

5.  DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time.

Authors:  Lindsey Chudley; Katy McCann; Ann Mander; Torunn Tjelle; Juan Campos-Perez; Rosemary Godeseth; Antonia Creak; James Dobbyn; Bernadette Johnson; Paul Bass; Catherine Heath; Paul Kerr; Iacob Mathiesen; David Dearnaley; Freda Stevenson; Christian Ottensmeier
Journal:  Cancer Immunol Immunother       Date:  2012-05-22       Impact factor: 6.968

6.  Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond.

Authors:  C M Britten; S Janetzki; S H van der Burg; C Huber; M Kalos; H I Levitsky; H T Maecker; C J M Melief; J O'Donnell-Tormey; K Odunsi; L J Old; G Pawelec; B O Roep; P Romero; A Hoos; M M Davis
Journal:  Cancer Immunol Immunother       Date:  2010-11-16       Impact factor: 6.968

7.  Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.

Authors:  Cedrik Michael Britten; Sylvia Janetzki; Leah Ben-Porat; Timothy M Clay; Michael Kalos; Holden Maecker; Kunle Odunsi; Michael Pride; Lloyd Old; Axel Hoos; Pedro Romero
Journal:  Cancer Immunol Immunother       Date:  2009-03-04       Impact factor: 6.968

8.  Toward the harmonization of immune monitoring in clinical trials: quo vadis?

Authors:  C M Britten; S Janetzki; S H van der Burg; C Gouttefangeas; A Hoos
Journal:  Cancer Immunol Immunother       Date:  2007-08-25       Impact factor: 6.968

9.  Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).

Authors:  Sylvia Janetzki; Katherine S Panageas; Leah Ben-Porat; Jean Boyer; Cedrik M Britten; Timothy M Clay; Michael Kalos; Holden T Maecker; Pedro Romero; Jianda Yuan; W Martin Kast; Axel Hoos
Journal:  Cancer Immunol Immunother       Date:  2007-08-25       Impact factor: 6.968

10.  The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.

Authors:  C M Britten; C Gouttefangeas; M J P Welters; G Pawelec; S Koch; C Ottensmeier; A Mander; S Walter; A Paschen; J Müller-Berghaus; I Haas; A Mackensen; T Køllgaard; P thor Straten; M Schmitt; K Giannopoulos; R Maier; H Veelken; C Bertinetti; A Konur; C Huber; S Stevanović; T Wölfel; S H van der Burg
Journal:  Cancer Immunol Immunother       Date:  2007-08-25       Impact factor: 6.968
View more
  2 in total

1.  Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.

Authors:  Anna Sambor; Ambrosia Garcia; Mark Berrong; Joy Pickeral; Sara Brown; Wes Rountree; Ana Sanchez; Justin Pollara; Nicole Frahm; Sarah Keinonen; Gustavo H Kijak; Mario Roederer; Gail Levine; M Patricia D'Souza; Maria Jaimes; Richard Koup; Thomas Denny; Josephine Cox; Guido Ferrari
Journal:  J Immunol Methods       Date:  2014-04-29       Impact factor: 2.303

Review 2.  Mechanisms of tumor immunotherapy, with a focus on thoracic cancers.

Authors:  Simona Ferro; Veronica Huber; Licia Rivoltini
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.